Latest Articles

Publication Date
Senescence-Driven Remodeling Defines an Aggressive and Immunomodulatory Subtype of Endometriosis.

Endometriosis is a benign yet invasive disease characterized by ectopic endometrial growth and immune remodeling. While emerging evidence implicates cellular senescence in disease progression, the underlying mechanisms remain largely undefined. …

Published: March 28, 2026, midnight
Charting the nerve-immune axis in endometriosis.

Endometriosis is increasingly recognized as a systemic disorder involving complex interactions between nerves and immune cells, driving chronic pain and inflammation beyond the initial theories. Recent breakthroughs highlight aberrant sensory …

Published: March 26, 2026, midnight
Insilico Medicine and ASKA Pharmaceutical Partner to Discover Novel Drug Targets for Endometriosis, Fibroids and Adenomyosis - Femtech Insider

Insilico Medicine and ASKA Pharmaceutical Partner to Discover Novel Drug Targets for Endometriosis, Fibroids and Adenomyosis Femtech Insider

Published: March 25, 2026, 12:34 p.m.
Insilico Medicine and ASKA Pharma expand partnership to discover novel targets for women’s health - BioSpectrum Asia

Insilico Medicine and ASKA Pharma expand partnership to discover novel targets for women’s health BioSpectrum Asia

Published: March 25, 2026, 6:37 a.m.
ACOG Endometriosis Guidelines Target Diagnostic Delays.

Published: March 20, 2026, midnight
Biomaterials for endometriosis treatment: Design, advances, and prospects.

Endometriosis is a chronic gynecological disease characterized by the presence of ectopic endometrium. Achieving effective therapeutic outcomes for endometriosis has always been a significant clinical hurdle because of the high …

Published: March 19, 2026, midnight
Autophagy and Lysosomal Dysregulation in Endometriosis: Therapeutic Opportunities and Molecular Insights.

Published: March 17, 2026, midnight
Exploring endometriosis through 3D in vitro models: A narrative review.

Endometriosis is a prevalent inflammatory disease affecting approximately one in ten women, characterized by endometrial tissue outside the uterus. Despite its high incidence, treatment options are limited, and the underlying …

Published: March 17, 2026, midnight
HerAnova Commercializes Blood Test for Endometriosis Detection, Targeting Years-Long Diagnostic Delays - R&D World

HerAnova Commercializes Blood Test for Endometriosis Detection, Targeting Years-Long Diagnostic Delays R&D World

Published: March 16, 2026, 9:31 p.m.
Universal, Off-the-Shelf Immunotherapy Targets and Eliminates Endometrial Cancer - Bioengineer.org

Universal, Off-the-Shelf Immunotherapy Targets and Eliminates Endometrial Cancer Bioengineer.org

Published: March 16, 2026, 9:20 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!